Tryp Therapeutics
from OTCQB Podcast Hosted by OTC Markets Group
Tryp Therapeutics (OTCQB: TRYPF) is a pharmaceutical company focused on identifying and developing clinical-stage compounds for the treatment of rare and other diseases with high unmet medical needs through regulatory pathways. CEO Gregory McKee joins us to discuss the current progress the company has had with scientific collaborations and clinical activities. View Podcast Transcript for Tryp Therapeutics
Embed this episode
No transcript yet.
Similar podcasts
Frequently asked questions
How long is this episode of OTCQB Podcast?
This episode is 20 minutes long.
When was this OTCQB Podcast episode published?
This episode was published on May 26, 2021.
Can I download this OTCQB Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.